Breaking
Top Investing Channel
Archive

July 23, 2025

Browsing

Tech Taps the Brakes, Homebuilders Hit the Gas: See the Rotation on StockCharts Today

The stock market feels like it’s holding its breath ahead of Big Tech earnings. The first two days of the trading week were mostly quiet, but Tuesday gave us a few nuggets worth chewing on.

The S&P 500 ($SPX) squeaked out another record close, up by a modest +0.06%. It’s barely a blip, but it keeps the uptrend intact.

Tech momentum slowed down a tad, but we didn’t see a wave of selling. It was more like a little profit-taking after a strong run. No reason to hit the panic button just yet.

StockCharts Tip: Head to the Market Summary page and take a glance at the Market Factors panel. On Tuesday, Large-Cap Growth and Large-Cap Momentum were the only factors in the red (see image below).

FIGURE 1. MARKET FACTORS PANEL IN THE MARKET SUMMARY PAGE. Here you see the one-day performance metrics of the factors. You can change the timeframe using the dropdown menu at the top of the page. Image source: StockCharts.com. For educational purposes.

In the US Sectors panel in the Market Summary page, Technology was the lone S&P 500 sector that finished lower. Tuesday’s action can be seen in the StockCharts MarketCarpet of the S&P 500, based on a one-day performance.

FIGURE 2. MARKETCARPET FOR THE S&P 500. The Technology sector took a bit of a hit on Tuesday, but other sectors saw gains. Image source: StockCharts.com. For educational purposes.

The big names — NVIDIA (NVDA), Microsoft Corp. (MSFT), Amazon.com (AMZN), Meta Platforms (META), and Broadcom (AVGO) — were all in the laggard camp. This pause in tech stocks comes right before a wave of Big Tech earnings.

Some of the big tech companies reporting earnings this week are Alphabet, Inc. (GOOGL), Tesla, Inc. (TSLA), and International Business Machines (IBM). All three report on Wednesday after the close. If GOOGL and TSLA come in hot with solid numbers and upbeat guidance, the S&P 500 and Nasdaq Composite ($COMPQ) could catch a tailwind. (Fun fact: both stocks closed higher on Tuesday.)

Despite Tuesday’s tech wobble, major support levels are holding. The Nasdaq Composite remains comfortably above its 20-day exponential moving average (EMA), and breadth is improving (see chart below).

FIGURE 3. DAILY CHART OF THE NASDAQ COMPOSITE. The index is above its 20-day exponential moving average, and market breadth is improving. Chart source: StockCharts.com. For educational purposes.

Small Caps Still in the Game

We’re also seeing small-cap stocks rising. When small-caps participate in the market’s upside move, it’s an indication of a healthy stock market. Healthcare stocks represent a significant portion of the small-cap indexes, which explains why Health Care was the top-performing sector on Tuesday. 

Another area that stole the spotlight was homebuilders. The SPDR S&P Homebuilders ETF (XHB) broke above its 200-day simple moving average (SMA), a positive sign for the struggling industry group (see chart below). Its Relative Strength Index (RSI) indicates that momentum is relatively strong.

FIGURE 4. SPDR S&P HOMEBUILDERS ETF (XHB). The ETF broke above its 200-day simple moving average, and momentum is relatively strong. XHB has underperformed SPY over the last year. Chart source: StockCharts.com. For educational purposes.

Over the last year, XHB has lagged the SPDR S&P 500 ETF (SPY) by roughly 18%. Strong earnings from DR Horton, Inc. (DHI) and PulteGroup, Inc. (PHM), however, have given the group a welcome boost, even with a soft housing backdrop. We’ll get the June Existing Home Sales data on Wednesday. A stronger-than-expected report could add fuel to XHB’s rally.

StockCharts Tip: The XHB chart above is part of the  Market Summary ChartPack, which is free for StockCharts subscribers. Install it, and you’ll have a ready-to-use list of charts for days like this.

Also worth a peek is the U.S. Dow Jones Home Construction Index ($DJUSHB), which topped the Dow Industries list (check the US Industries panel in Market Summary and hit the Dow Industries tab).

Gold and Silver Nudge Higher

While tech cooled and home builders heated up, precious metals prices climbed higher. Gold ($GOLD) rose 0.92% and silver ($SILVER) gained 0.94%. Gold sits just under its all-time high, and silver is back to levels we haven’t seen since 2011.

The Big Picture: Still a Healthy Market Environment

None of Tuesday’s actions suggests a crack in the market’s growth story. We are in the thick of earnings season, and that always brings uncertainty and volatility. Expectations are high for Big Tech, especially in light of a weaker dollar. Stay patient, watch the price action, and let the charts guide your next move.

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

10 Biggest Cannabis Stocks in the US and Canada

The cannabis market has faced unexpected challenges in 2025, despite initial optimism for rescheduling in the US. 

While US federal regulatory uncertainty and banking remain persistent, companies are shifting focus to match changes in consumer behavior. The growing popularity of edibles and rising interest in cannabis-infused beverages reflect evolving demand in a persevering industry.

Cannabis companies in the sector continue to move forward and develop their offerings, and with potential catalysts ahead, some investors are interested in getting involved. Looking at the key players is often a good place to get started, so this list of US and Canadian cannabis stocks covers the companies with the largest presence in two major cannabis ETFs.

This list of the biggest publicly traded cannabis companies was put together based on the top-weighted cannabis stocks included in the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) as of July 16, 2025. Share price information for the companies was accurate as of that time.

US cannabis market

Cannabis is federally illegal in the US, but state market openings have allowed some operators to thrive. Typically these firms set up vertically integrated businesses with a focus on branded products, retail networks and licenses.

While these companies have adapted to regulatory challenges, they have much to gain from country-level reform in the US, and are eager to see more welcoming federal laws that will allow their businesses to develop further.

Top cannabis stocks in the AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF provides exposure to public companies exclusively operating within the US cannabis industry. By investing in companies that are working in states with clear guidelines, MSOS gives investors a way to be more selective about the types of cannabis companies they’re investing in.

1. Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)

ETF weight: 32.06 percent
Market cap: US$1.36 billion
Share price: US$5.72

Green Thumb Industries is a multi-state operator (MSO) with headquarters in Chicago, Illinois.

The company is involved in the entire process of the industry, from cultivating and producing cannabis products to selling them in its own retail stores, of which there are many across the United States. Green Thumb Industries owns a portfolio of well-known cannabis brands like Rythm, Beboe, Dogwalkers, Incredibles and Doctor Solomon’s.

2. Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)

ETF weight: 22.59 percent
Market cap: US$781.51 million
Share price: US$4.09

Trulieve is another major player in the cannabis industry, with a strong focus on medical cannabis. The company offers a diverse selection of cannabis products, including flower, pre-rolls, concentrates, edibles, topicals and more.

Vertically integrated, Trulieve Cannabis has a dominant market share in its home state of Florida, as well as in Arizona and Pennsylvania. In June 2024, the company opened its 200th dispensary in the United States.

3. Curaleaf Holdings (TSX:CURA,OTCQX:CURLF)

ETF weight: 15.37 percent
Market cap: US$764.16 million
Share price: US$1.00

Curaleaf Holdings has a significant presence in the US cannabis market, with around 150 dispensaries and several cultivation centers across 17 states. The company is also continuing its expansion into the European cannabis sector, where it already has a strong presence. Curaleaf has a wide range of brands covering a variety of cannabis product types, including flower, vapes, edibles and hemp-derived THC beverages.

4. Glass House Brands (CBOE:GLAS.A.U,OTC Pink:GHBWF)

ETF weight: 7.32 percent
Market cap: US$269.57 million
Share price: US$5.40

Glass House Brands is a vertically integrated cannabis company with a focus on the California market. The company is has placed an emphasis on sustainable practices at its large-scale cultivation facility in Camarillo, California. Glass House Brands is also a major producer and wholesaler of cannabis biomass and cannabis oil to other manufacturers and extractors in the industry.

Glass House offers a diverse range of cannabis products through its various brands and retail operations, including edibles and wellness products under its Mama Sue Wellness brand.

5. Cresco Labs (CSE:CL,OTCQX:CRLBF)

ETF weight: 5.53 percent
Market cap: US$235.9 million
Share price: US$0.53

Cresco Labs is a vertically integrated multi-state cannabis operator in the United States. A leading US cannabis company, it is known for its strong brands like Cresco, High Supply and Good News.

Cresco Labs controls its supply chain from cultivation to retail, offering a wide range of products. While it has its own stores, it focuses heavily on wholesale, getting its products into dispensaries across the country.

Canadian cannabis market

In 2018, Canada became the first G7 nation to legalize adult-use cannabis and create its own streamlined program regulated by both federal and provincial powers. Since then, companies working in the country have faced ups and downs in dealing with tight marketing rules, high tax rates and ongoing competition with the unregulated market.

Top cannabis stocks in the Global X Marijuana Life Sciences Index ETF

The Global X Marijuana Life Sciences Index ETF was the first cannabis ETF available in Canada, and it holds a variety of publicly traded companies involved in cannabis, along with several non-flower companies.

While HMMJ does not invest in US-based multi-state operators, it does have exposure to the US market through Canadian companies that have interests in the US cannabis industry. Overall, HMMJ is designed to give investors broad exposure to the cannabis industry, with a particular focus on North American companies.

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

ETF weight: 16.47 percent
Market cap: US$7.02 billion
Share price: US$116.08

Jazz Pharmaceuticals is a global biopharmaceutical company focused on developing and commercializing medicines for people with serious diseases, often with limited or no other options. They have a diverse portfolio of products in areas like sleep disorders, cancer and epilepsy.

Jazz Pharmaceuticals’ cannabis business stems from their 2021 acquisition of GW Pharmaceuticals and its epilepsy medicine Epidiolex for a whopping US$7.2 billion. This made big waves as it was one of the largest moves by a traditional pharmaceutical company into the cannabis space.

2. Cronos Group (NASDAQ:CRON,TSX:CRON)

ETF weight: 13.14 percent
Market cap: US$774.69 million
Share price: US$2.01

Cronos Group is the Canada-based company behind the Spinach, Peace Naturals and Lord Jones cannabis brands. In Canada, Cronos’ Spinach brand is in the top three for retail sales in the flower and edible categories.

The company also has a presence in Israel and Germany with its brand Peace Naturals. In late 2023, the company re-entered the German medical cannabis market through its partnership with a German medical cannabis company called Cansativa Group. Cronos serves the Israeli market through its subsidiary Cronos Israel.

3. Innovative Industrial Properties (NYSE:IIPR)

ETF weight: 11.28 percent
Market cap: US$1.51 billion
Share price: US$53.99

Innovative Industrial Properties is a real estate investment trust that provides specialized real estate opportunities for cannabis companies in 19 states. Its properties mostly consist of processing plants, greenhouses and warehouses, with retail spaces making up a small percentage of its portfolio.

The firm has provided long-term absolute net lease agreements to some of the cannabis industry’s biggest names, including Green Thumb, TILT Holdings (NEO:TILT,OTCQB:TLLTF), Ascend Wellness (CSE:AAWH.U,OTCQX:AAWH) and Curaleaf. The company’s sale-leaseback program has helped cannabis companies access a source of capital, a much-needed workaround in the US where there are fewer traditional financing options.

4. Scotts Miracle-Gro Co (NYSE:SMG)

ETF weight: 10.74 percent
Market cap: US$3.92 billion
Share price: US$67.92

Scotts Miracle-Gro is a leader in lawn and garden products, but its involvement in the cannabis industry comes through its Hawthorne Gardening Company subsidiary. Hawthorne is an ancillary provider, supplying essential hydroponic and indoor growing equipment, nutrients, lighting and environmental control systems for large-scale cannabis production.

5. SNDL (NASDAQ:SNDL)

ETF weight: 7.8 percent
Market cap: US$383.4 million
Share price: US$1.49

SNDL, formerly known as Sundial Growers, is the largest private-sector liquor and cannabis retailer on the Canadian market. They cultivate and sell cannabis products under various brands, including Top Leaf, Sundial Cannabis, Palmetto and more. They focus on premium indoor cultivation and have a strong presence in the Canadian market.

SNDL has faced financial challenges in the past, but in Q1 2025 the company’s cannabis business revenue grew year-over-year for the 13th consecutive quarter. The company has continued to make strategic investments in 2025.

FAQs for investing in cannabis

Are cannabis stocks worth investing in?

Each investor will have to think and act for themselves to manage their own risk exposure, but it’s no secret that cannabis stocks have taken a beating for some time now. While financial experts point to the long-term upside of US operators as more state markets expand, the stock market has not been kind to these names lately.

Are cannabis stocks considered a high- or low-risk investment?

Cannabis investments are extremely young in the grand scheme of the investment universe. There is an exciting and refreshing element to these stocks, but the market has always been characterized by volatility and unpredictability.

While wild, spontaneous swings in the open market have become less common, cannabis stocks are often moved — both positively and negatively — by big pieces of market news or legalization updates.

Why do people buy cannabis stocks?

Investors may choose to get exposure to the cannabis market as a way to participate in the development of a new drug market with consumer packaged goods capabilities. Some participants are bullish on the industry’s long-term outlook and expect more welcoming laws in the US and across the world to provide upward momentum.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

Perth, Australia (ABN Newswire) – Altech Batteries Limited (ASX:ATC,OTC:ALTHF) (FRA:A3Y) (OTCMKTS:ALTHF) is pleased to announce an update on funding of the CERENERGY(R) sodium-chloride solid-state battery project in Saxony, Germany.

DEBT PROCESS

As previously mentioned, Altech has engaged ten commercial banks and two venture debt funds in the first round of financing discussions, receiving largely positive initial feedback. Based on this feedback, the Company has selected a preferred financial institution- a European bank with a proven track record in providing debt funding for technology-driven projects, particularly those within the innovation sector.

Although the mandate has not yet been formally executed, Altech intends to make an official announcement once this step is complete.

Meanwhile, the bank’s commercial and technical teams have been diligently conducting a comprehensive review of the Cerenergy projects and its technology. The technical due diligence process is critical for ensuring that the project meets the bank’s financing and risk criteria. As part of this process the onsite Altech experts are in detailed discussions with the bank’s representative. The banks have visited Dresden and the Fraunhofer testing facilities and visit Hermsdorf, Germany where the prototype production is located in the coming weeks, which will be a key step in concluding the technical evaluation.

In parallel with these efforts, Altech is progressing discussions for securing a federal government guarantee, which would further strengthen its ability to secure the necessary debt funding for the project. Officials from the Ministry of Finance have already been briefed on the initiative, and the due diligence process for the application is actively underway. This federal guarantee will serve as an underwriter and therewith derisk any debt funding for the project substantially.

EQUITY FUNDING

In parallel with ongoing debt financing efforts, the Group has engaged several equity advisers to assist in securing the equity component of the project’s funding package. As part of this strategy, Altech plans to divest a minority interest in the project to one or two strategic investors. This partial divestment is intended to attract investors who can contribute not only capital, but also strategic value, aligning with the CERENERGY(R) project’s long-term goals of growth and sustainability.

The Group on one hand is specifically targeting large utility companies, data centre operators, investment funds, and corporations that are deeply committed to the green energy transition and on the other hand industrial partners with access and know-how and resources relevant to Cerenergy battery production, implementation or market access. These potential partners are seen as ideal due to their strong alignment with the project’s sustainable energy focus and their ability to provide significant financial support. Progress in equity discussions has been promising, with several Non-Disclosure Agreements (NDAs) signed, enabling deeper engagement with prospective investors. Additionally, draft term sheets have been circulated to interested parties, outlining the key terms and conditions for investment. These documents provide a foundation for negotiations and facilitate more detailed discussions around the equity stake and partnership structure.

The decision to divest part of the project is strategically aimed at easing the Company’s financial burden while bringing in experienced partners who can contribute to the project’s success. By securing both equity and debt financing, Altech aims to finalize the full funding package, ensuring the timely construction and commissioning of the CERENERGY(R) battery plant. Moving forward, the focus will be on advancing these discussions and converting interest into formal commitments, which are critical for the project’s progression.

GRANT APPLICATIONS

Altech has been actively applying for various grants offered by the State of Saxony, Federal Government of Germany, and the European Union. The State of Saxony and Brandenburg, along with the European Union, offer substantial support for renewable energy projects, including grants aimed at converting lignite coal to renewable energy sources. These grants are part of broader efforts to transition regions dependent on fossil fuels toward sustainable energy solutions. Altech’s site, located in these areas, stands to benefit from various funding programs designed to support clean energy projects, including EU grants for energy transformation and innovation. Altech has applied for several of these grants to advance its CERENERGY(R) project, securing essential financial backing for technology development, high-tech industries, expert employment and infrastructure upgrades.

OFFTAKE ARRANGEMENTS

Altech has secured three key Offtake Letters of Intent (LOIs) for 100% of its CERENERGY(R) production.

1. Zweckverband Industriepark Schwarze Pumpe (ZISP): An agreement was signed on 13 September 2024 for ZISP to purchase 30 MWh of energy storage capacity annually, consisting of 1MWh GridPacks, for the first five years of production. The purchase is contingent on performance tests and battery specifications meeting customer requirements.

2. Referenzkraftwerk Lausitz GmbH (RefLau): A second LOI was executed with RefLau, a joint venture between Enertrag SE and Energiequelle GmbH. RefLau will buy 30 MWh of CERENERGY(R) storage n the first year, increasing to 32 MWh annually for the next four years. Additionally, Altech will purchase green electricity for its planned production plant.

3. Axsol GmbH: A third LOI was signed with Axsol, a leading renewable energy solutions provider. Axsol will exclusively distribute CERENERGY(R) batteries to the Western defense industry, facilitating early market entry and sales. These agreements are crucial for financing and advancing the CERENERGY(R) project.

 

About Altech Batteries Ltd:  

Altech Batteries Limited (ASX:ATC,OTC:ALTHF) (FRA:A3Y) is a specialty battery technology company that has a joint venture agreement with world leading German battery institute Fraunhofer IKTS (‘Fraunhofer’) to commercialise the revolutionary CERENERGY(R) Sodium Alumina Solid State (SAS) Battery. CERENERGY(R) batteries are the game-changing alternative to lithium-ion batteries. CERENERGY(R) batteries are fire and explosion-proof; have a life span of more than 15 years and operate in extreme cold and desert climates. The battery technology uses table salt and is lithium-free; cobalt-free; graphite-free; and copper-free, eliminating exposure to critical metal price rises and supply chain concerns.

The joint venture is commercialising its CERENERGY(R) battery, with plans to construct a 100MWh production facility on Altech’s land in Saxony, Germany. The facility intends to produce CERENERGY(R) battery modules to provide grid storage solutions to the market.

 

 

Source:
Altech Batteries Ltd

 

 

Contact:
Corporate
Iggy Tan
Managing Director
Altech Batteries Limited
Tel: +61-8-6168-1555
Email: info@altechgroup.com

Martin Stein
Chief Financial Officer
Altech Batteries Limited
Tel: +61-8-6168-1555
Email: info@altechgroup.com

 

 

News Provided by ABN Newswire via QuoteMedia

This post appeared first on investingnews.com

Orange juice importer says Brazil tariffs will squeeze American consumers

Orange juice prices could rise by 20% to 25%, according to Johanna Foods, a small U.S. business suing the White House over tariffs threatened against Brazil.

President Donald Trump said in a July 9 letter to President Luiz Inacio Lula da Silva that he would apply a 50% tariff to all imports from Brazil starting Aug. 1.

Trump said the high tariff rate was necessary because of ‘the way Brazil has treated former President Bolsonaro.’

Prosecutors in Brazil have alleged that Bolsonaro was part of a scheme that included a plan to assassinate the country’s current president, who defeated him in the last election, and Supreme Federal Court Justice Alexandre de Moraes. Bolsonaro has denied any wrongdoing.

Trump also said Brazil was censoring U.S.-based social media platforms and was running “unsustainable Trade Deficits” with the United States.

However, the United States has a goods trade surplus with Brazil — more than $7 billion last year, according to data from the Office of the U.S. Trade Representative.

Johanna Foods, which says it supplies nearly 75% of all private label “not from concentrate” orange juice to customers in the U.S., says those arguments do not constitute an economic emergency and therefore the president does not have the power to levy this tariff.

“The Brazil Letter does not refer to any legal or statutory authority under which the Brazil Tariff can be imposed by the President,” the company’s attorney Marc Kaplin writes in a filing.

“The Brazil Letter does not constitute a proper executive action, is not an Executive Order, does not reference or incorporate any Executive Orders or modify or amend any existing Executive Order,” the attorney continued.

The company said some of its customers include Walmart, Aldi, Wegman’s, Safeway and Albertsons.

Johanna Foods CEO Robert Facchina said the duty would result in an estimated $68 million hit, exceeding any single year of profits since the company was created in 1995.

“The Brazil Tariff will result in a significant, and perhaps prohibitive, price increase in a staple American breakfast food,” the lawsuit reads.

“The not from concentrate orange juice ingredients imported from Brazil are not reasonably available from any supplier in the United States in sufficient quantity or quality to meet the Plaintiffs’ production needs.”

Orange juice prices have already been rising across the country. Over the last year, the average price of a 16-ounce container rose 23 cents, or more than 5%, to $4.49, according to the Bureau of Labor Statistics.

Orange juice futures, the global benchmark that tracks the commodity, have also jumped recently. During the last month, they are up nearly 40%, with most of that increase coming on the heels of Trump’s threat.

Brazil’s Supreme Court ruled last month that social media companies can be held accountable for the content posted on their platforms. Elon Musk’s social media site, X, was also briefly banned last year in Brazil after Musk refused to comply with a court request to ban some accounts.

Facchina says layoffs of union manufacturing employees, administrative staff and a reduced production capacity at the company’s Flemington, New Jersey, and Spokane, Washington, facilities are near-certain should these tariffs go into effect. Johanna Foods employs almost 700 people across Washington state and New Jersey.

Brazil was the 18th-largest source of U.S. goods imports last year, with more than $42 billion worth of imports entering the country, according to U.S. International Trade Commission data.

In its legal filing, the company asks the Court of International Trade to declare that the International Emergency Economic Powers Act does not grant Trump the statutory authority to impose the tariffs against Brazil, and that the president has not identified a national emergency or “unusual and extraordinary threat” as required by the IEEPA law to impose the tariffs.

In response to the lawsuit, a White House spokesperson said the administration is ‘legally and fairly using tariff powers that have been granted to the executive branch by the Constitution and Congress to level the playing field for American workers and safeguard our national security.”

This post appeared first on NBC NEWS